Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
Open Access
- 24 February 2016
- journal article
- research article
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 9 (1) , 1-10
Abstract
Wilms tumor (WT) has a not completely elucidated pathogenesis. DNA copy number alterations (CNAs) are common in cancer, and often define key pathogenic events. The aim of this work was to investigate CNAs in order to disclose new candidate genes for Wilms tumorigenesis. Array-CGH of 50 primary WTs without pre-chemotherapy revealed a few recurrent CNAs not previously reported, such as 7q and 20q gains, and 7p loss. Genomic amplifications were exclusively detected in 3 cases of WTs that later relapsed, which also exhibited an increased frequency of gains affecting a 16.2 Mb 1q21.1-q23.2 region, losses at 11p, 11q distal, and 16q, and WT1 deletions. Conversely, aneuploidies of chromosomes 13 and 19 were found only in WTs without further relapse. The 1q21.1-q23.2 gain associated with WT relapse harbours genes such as CHD1L, CRABP2, GJA8, MEX3A and MLLT11 that were found to be over-expressed in WTs. In addition, down-regulation of genes encompassed by focal deletions highlighted new potential tumor suppressors such as CNKSR1, MAN1C1, PAQR7 (1p36), TWIST1, SOSTDC1 (7p14.1-p12.2), BBOX and FIBIN (11p13), and PLCG2 (16q). This study confirmed the presence of CNAs previously related to WT and characterized new CNAs found only in few cases. The later were found in higher frequency in relapsed cases, suggesting that they could be associated with WT progression.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo (BR) (2010/00223-1)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2008/57887-9)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (400140/2014-4)
This publication has 46 references indexed in Scilit:
- Genetics of pediatric renal tumorsPediatric Nephrology, 2012
- Genomic profiling by whole‐genome single nucleotide polymorphism arrays in Wilms tumor and association with relapseGenes, Chromosomes and Cancer, 2012
- THE ANIMAL WITHIN: CARCINOGENESIS AND THE CLONAL EVOLUTION OF CANCER CELLS ARE SPECIATION EVENTS SENSU STRICTOEvolution, 2009
- Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562Clinical Cancer Research, 2009
- Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumorGenes, Chromosomes and Cancer, 2009
- Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsAmerican Journal of Hematology, 2009
- Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) studyEuropean Journal of Cancer, 2009
- Regulation of CRABP-II expression by MycN in Wilms tumorExperimental Cell Research, 2008
- Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinomaHepatology, 2008
- STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experimentsGenome Research, 2006